BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2415154)

  • 1. Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women.
    Rees MC; Cederholm-Williams SA; Turnbull AC
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1164-8. PubMed ID: 2415154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
    Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
    Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
    Edlund M; Blombäck M; He S
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):593-8. PubMed ID: 12960614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea.
    Rees MC; Anderson AB; Demers LM; Turnbull AC
    Br J Obstet Gynaecol; 1984 Jul; 91(7):673-80. PubMed ID: 6589016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of certain coagulation factors in menstrual fluid from women with normal blood loss.
    Cederholm-Williams SA; Rees MC; Turnbull AC
    Thromb Haemost; 1984 Dec; 52(3):224-5. PubMed ID: 6531747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumption of fibrinolytic proteins in menstrual fluid from women with normal menstrual blood loss.
    Cederholm-Williams SA; Rees MC; Turnbull AC
    J Clin Pathol; 1984 Aug; 37(8):879-81. PubMed ID: 6540788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
    Dockeray CJ; Sheppard BL; Daly L; Bonnar J
    Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss.
    Hahn L; Cederblad G; Rybo G; Pehrsson NG; Bengtsen KK
    Br J Obstet Gynaecol; 1976 Dec; 83(12):974-80. PubMed ID: 1009035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The coagulation and fibrinolysis activities of the blood during various phases of labor].
    Schander K; Wahl W; Rehm A
    Fortschr Med; 1979 Oct; 97(38):1696-702. PubMed ID: 92443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.
    Hahn L; Rybo G
    Acta Obstet Gynecol Scand; 1975; 54(2):119-27. PubMed ID: 1136717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-like activity in uterine fluid.
    Foley ME; Griffin BD; Zuzel M; Aparicio SR; Bradbury K; Bird CC; Clayton JK; Jenkins DM; Scott JS; Rajah SM; McNichol GP
    Br Med J; 1978 Jul; 2(6133):322-4. PubMed ID: 687899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Sidelmann J
    Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procoagulant and fibrinolytic activities of gastric and colorectal cancer.
    Szczepański M; Lucer C; Zawadzki J; Tołłoczko T
    Int J Cancer; 1982 Sep; 30(3):329-33. PubMed ID: 6890044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular smooth muscle alpha-actin distribution around endometrial arterioles during the menstrual cycle: increased expression during the perimenopause and lack of correlation with menorrhagia.
    Abberton KM; Taylor NH; Healy DL; Rogers PA
    Hum Reprod; 1996 Jan; 11(1):204-11. PubMed ID: 8671187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic and fibrinolytic properties of peritoneal fluid in the menstrual cycle.
    Bouckaert PX; van Wersch JW; Schellekens LA; Evers JL; Rolland R
    Br J Obstet Gynaecol; 1984 Mar; 91(3):256-9. PubMed ID: 6422977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
    Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
    Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin degradation products in sera of women with normal menstruation and menorrhagia.
    Basu HK
    Br Med J; 1970 Jan; 1(5688):74-5. PubMed ID: 5411448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic properties of "peritoneal" blood used for reinfusion in gynecologic practice].
    Tikhomirova NI; Khvatov VB
    Probl Gematol Pereliv Krovi; 1977 Feb; (2):38-42. PubMed ID: 141666
    [No Abstract]   [Full Text] [Related]  

  • 19. A characterization of the coagulant and fibrinolytic profile of human pancreatic carcinoma cells.
    Kakkar AK; Chinswangwatanakul V; Tebbutt S; Lemoine NR; Williamson RC
    Haemostasis; 1998; 28(1):1-6. PubMed ID: 9885363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
    Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
    Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.